To evaluate the genetic variability of human parvovirus B19, the complete coding region of the VP1/VP2 structural proteins of 29 B19 isolates obtained from 25 infected patients were sequenced and compared with each other and with two previously published B19 isolates. The VP1/VP2 gene was amplified by PCR using B19-specific oligonucleotide primers and the amplification products were sequenced directly. Overall, the average nucleotide and predicted amino acid identity among B19 isolates was high. Sequential virus isolates from the same cases and isolates obtained from two cases linked by transmission in the same household were essentially identical. Sequence variation was minimal among isolates obtained from a single community-wide B19 outbreak, ranging between 0 and 10 (0,4%) base substitutions, although there appeared to be more than one genetic lineage circulating in the outbreak. A comparison with 18 additional isolates from distinct epidemiological settings found greater variability. These isolates differed from each other by between 11 (0.5%) and 112 (4.8%) base substitutions. B19 isolates from Xi'an, China, were significantly different from other isolates at both the nucleoticle and amino acid levels, and were more closely related to a single isolate from Japan, obtained 10 years earlier, than to isolates from other countries. Isolates examined in this study included distinct genotypes from patients with similar clinical presentations and similar genotypes from patients with diverse clinical presentations. These data suggest that geographically defined genetic lineages of B19 may exist and that no particular B19 genotype was associated with a particular clinical outcome.
Introduction
Human parvovirus B19 is a member of the genus Erythrovirus of the family Parvoviridae (Murphy et al., 1995) . The genome of B19 consists of either positive-or negativesense ssDNA of approximately 5"5 kb, with self-priming hairpin termini. The genome encodes a non-structural protein, NS1, and two structural proteins that comprise the B19 capsid, the minor structural protein, VP 1, and major structural protein, VP2. The two structural proteins are encoded in the same reading flame (referred to throughout as VP1/VP2) and the entire nucleotide sequence of VP2 (554 aa) lies within the VP1 (781 aa) coding region. The structural proteins of BI9 Author for correspondence: Dean D. Erdman.
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Infection with BI9 can cause a wide spectrum of clinical manifestations (T6r6k, 1992) . Although the most commonly recognized illness associated with infection is the mild childhood rash, erythema infectiosum (EI), B19 can also cause more severe disease. In people with underlying haemolytic disorders, B19 infection can lead to a severe transient aplastic crisis (TAC) . B19 infection of the developing fetus can cause spontaneous abortion, hydrops fetalis and fetal death. B19 infections have also been linked to cases of haemophagocytic syndrome, myocarditis, hepatitis, neurological disease and systemic vasculitis, but additional study is needed to confirm the role of B19 in these diseases.
Minor antigenic and genetic differences between B19 isolates have been demonstrated by monoclonal antibody reactivities (Brown et al., 1992) , restriction enzyme analysis of iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii iiii iiiii i ii iiiiii iiii (Chorba et al., 1986) .
t B19 isolates CHI3 and CHI2 were obtained from family members.
:1: Serological assays were performed as previously described (Erdman et al., 1991) . ND, Not determined.
the virus genome (Morinet eta] ., I986; Mori et al., 1987; Umene & Nunoue, 1990 and single-stranded conformational polymorphism analysis of PCR products (Kerr et aI., 1995) . The nucleotide sequence of the B19 genome has been reported for two isolates, Au (Shade et al., 1986) and Wi (Blundell et al., 1987) and partial sequence data from selected regions of the B19 structural protein genes have been reported for B19 isolates from Japan (Umene & Nunoue, 1991 and Italy (Gallinella et al., 1995) . Together, these reports suggest that the B19 genome is highly conserved (< 1% relative variability). Although distinct genetic types have been described, the importance of these differences to the clinical and epidemiological features of BI9 has yet to be determined.
In an effort to understand better the geographical distribution and transmission patterns of BI9 and to identify genetic markers that may account for the diversity of clinical manifestations, we sequenced the VPI/VP2 structural protein gene of multiple B19 isolates and compared them with each other and with previously published B19 sequences.
Methods
• B1 9 isolates and study subjects. A total of 29 BI9 isolates were obtained from 25 persons chosen to achieve geographical, temporal and clinical diversity (Table 1) . Nineteen B19 isolates were obtained from persons in the USA between i984 and 1994; seven isolates were from different communities (USA1 to 7) and 12 (USA8 to 15) were from a single community outbreak of B19 in Ohio in 1984 (Chorba et al., 1986) .
Eight Ohio isolates were obtained from the acute-phase serum of four persons each with TAC and EI to assess the genetic variability of B19 isolates circulating in the same outbreak. Four additional Ohio isolates were obtained from convalescent-phase serum specimens collected approximately 3 weeks later from all TAC cases to assess the genetic variability of B19 isolates obtained after short-term replication in the host. B19 isolates from two previously reported cases of systemic necrotizing vasculitis (Finkel et al., 1994) , USA4 and USA7, were obtained from specimens collected approximately 12 and 21 months after onset of symptoms, respectively. Ten other B19 isolates were obtained from Japan (JAP1), Korea (KORI, 2), Brazil (BRZ1), Venezuela (VENI), the UK (UK1), Ireland (IRE1) and China (CHI1, 2, 3). The three B19 isolates from China included a mother (CHId) and child (CHI2) pair which 
* Primer designations supersede those published by Durigon et al. (1993) . Notations 'f' and 'r' refer to forward and reverse primers, respectively. i-Sequence numbering is by Shade et al. (1986) .
presumably represented infections that occurred through house-hold transmission.
• Previously sequenced B19 isolates. The two previously sequenced B19 isolates compared in this study were Au (Shade e~ al., 1986) , isolated in the US in 1982 from a child with TAC, and Wi (Blundell et al., 1987) , isolated in the UK in 1973 from a healthy blood donor.
• Consensus sequence. For comparative purposes, a consensus sequence of the VP1/VP2 gene was deduced from all 31 B19 sequences.
Isolates from common epidemiological settings were each given a single weight in the analysis. Sequence numbering throughout is based on that of Shade et al. (1986) .
• Oligonucleotide primers. Oligonucleotide primers used for amplification and sequencing reactions are listed in Table 2 . Primers were located to facilitate sequencing of the VP1/VP2 gene in both forward and reverse directions and were designed using Oligo Primer Analysis Software (National Biosciences).
• PCR amplification. B19 DNA for sequencing was prepared by PCR amplification by a method previously described (Durigon et aI., 1993) using the primer pair P20f/P17r to generate a 2422 bp product containing the entire VP1/VP2 coding region (nucleotides 2444 to 2789). Where amplification was inefficient, primer pairs P2Of/P9r and P7f/P17r were used to obtain two smaller overlapping regions of 879 and 1683 bp.
• DNA sequencing. PCR products were purified using Wizard PCR Preps (Promega) and the sequencing reactions were performed using the DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems). The sequencing reaction mixtures were eluted through Centri-Sep Columns (Princeton Separations) and ethanol-precipitated to remove excess dye terminators and unincorporated primers. The purified DNA was then mixed with deionized formamide loading buffer, resolved by electrophoresis on a 6% polyacrylamide gel and analysed with an AB[ 373A Automated DNA Sequencer (Applied Biosystems). All procedures were performed according to the manufacturer's instructions. To minimize reading errors, all isolates were sequenced in both forward and reverse directions. Nucleotide substitutions were confirmed from a second PCR amplification product for isolates CH1, CH2, CH3 and all isolates from the Ohio community-wide B19 outbreak, USA8 through USA15.
• Data analysis. Sequence comparisons were made using Version 8"I of the Wisconsin Sequence Analysis Package (University of Wisconsin Genetics Computer Group; Devereux et al., 1984) . The dendrogram was generated using the uncorrected Distances and GrowTree evolutionary analysis programs by the neighbor-joining method.
Results

Comparison of the nucleotide and amino acid sequences among B19 isolates
Over the 2343 nucleotides of the VP1/VP2 gene, the 31 sequences differed from the consensus sequence by as few as two (0"I %) and as many as 99 (4"2 %) nucleotides and as few as zero and as many as 13 (1"7%) deduced amino acids (Table 3 ). All nucleotide differences between B19 isolates were base (1986) . Previously sequenced B19 strains include Au (Shade et al., 1986) and Wi (Blundell et al., 1987) .
Rectangles are drawn to highlight two different amino acid changes at the same position. substitutions; no insertions or deletions were identified. Multiple amino acid changes were noted at two positions, 3830/3831, where proline was replaced by alanine in CHI1, CHI2 and CHI3, and by leucine in USAS, and at 4035/4036, where serine was replaced by threonine in USA14 and by asparagine in CHI2 and CHI3. Nucleotide substitutions were fairly evenly distributed throughout the VP1/VP2 gene, with the exception of a highly conserved sequence of approximately 180 nucleotides located between positions 2971 and 3148 of the VP1 unique region at the VP1/VP2 junction (Fig. 1) . Predicted amino acid changes in the VP1/VP2 protein were clustered in three regions: (i) the first 131 amino acids at the N terminus of VP1; (ii) between amino acid positions 234 and 281 at the N terminus of VP2; and (iii) randomly distributed between positions 424 and 724 of the C-terminal half of VP1/VP2. A highly conserved region of approximately 144 amino acids was identified between positions 280 and 425.
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Genetic clustering
To assess the genetic relationships between the B19 isolates, a dendrogram was constructed using the neighborjoining method based on calculation of the similarity score obtained by pair-wise comparisons of the 31 BI9 VP1/VP2 nucleotide sequences (Fig. 2) . As illustrated, multiple isolates from the same cases and isolates from different cases within the same household exhibited the highest degree of genetic identity. Of the four cases from whom paired isolates were collected at different intervals, three (USA9"1 and 9"2; 10"1 and 10"2; 11"1 and II'2) were identical and the fourth (USAS"I and 8"2) had only a single silent nucleotide substitution at position 3694 (A ~ C). Similarly, the sequences of isolates from the mother and daughter (CHI2, CHI3) with household-acquired B19 infection were identical. A clear genetic relationship was also apparent between isolates from the same community-wide B19 outbreak in Ohio. With the exception of one outlier (USA11"1 and 11"2), isolates from the Ohio outbreak showed greater similarity (range 0 to 8 nt, median 3 nt) than isolates from different communities within the USA (range 15 to 30 nt, median 20 nt) or isolates from different countries (range 17 to 108 nt, median 26 nt). The outlier (USA11"1 and 11"2) grouped separately from the other seven Ohio isolates and probably represented a second genotype circulating in this community. Isolates from China (CHI1, CHI2, CIH3) formed a distinct cluster that appeared to be more closely related to the 1983 Japan isolate (JAP1) than to isolates from other countries. Two isolates from Seoul, Korea (KOR1, KOR2), obtained in different years, grouped together, as did the two isolates from the UK and Ireland (UK1, IRE1), isolated in the same year but from different communities. Overall, no genotypic grouping could be associated with a common clinical presentation; isolates with identical amino acid sequences (e.g. USA3, USA6, USAT, Fig, 2 . Dendrogram showing the genetic relationships of the 31 B19 isolates based on the VP1/VP2 coding region. Flagged isolates are from a single community-wide B1 9 outbreak (*) and from a mother and child with epidemiologically related B19 infection (**). j CHi2, China, 1992 ~' CHI3, China, 1992"* USA9, USA13, IRE1) were associated with diverse clinical presentations, whereas isolates with varied amino acid sequences (e.g. CHI1, 3, KORI, USA9) were associated with similar clinical presentations.
To minimize the amount of sequencing required to classify new B19 isolates, subsets of the VP1/VP2 coding region were compared to identify a region that would best approximate the genetic relationships derived from the whole gene. A 400 nucleotide region that codes for the N-terminal portion of VP2 (nt 3125 to 3525) gave a good approximation of the genetic relationships illustrated in Fig. 2 (data not shown) .
Discussion
Genetic variation among parvovirus B19 isolates has been previously described, but on a limited basis. To further this effort, we compared nucleotide sequence data from the complete coding region of the structural proteins of 31 B19 isolates obtained from diverse geographical settings and time periods. Overall, genetic similarities among our different B19 isolates were high and consistent with previous reports describing sequence variability over selected regions of the VP1/VP2 gene. Gallinella et al. (1995) reported 0"63 % average variability for the first 1000 bases of nine B19 isolates from Italy. Of 16 nucleotide substitutions identified among these isolates, eight (50%) corresponded to changes among our isolates or isolates previously sequenced. In separate studies, Umene & Nunoue (1991 sequenced multiple B19 isolates from Japan between nucleotide positions 3141 and 3411 of the region coding for the N terminus of VP2 and showed that sequence variability in this region correlated with the genome types (I, II, IIa, IIb, IV and unassigned) described by Mori et al. (1987) . Using this classification scheme, the authors identified two predominate B19 types responsible for major outbreaks in Japan in 1981 (Umene & Nunoue, 1990 . Of interest, our 1983 Japan isolate possessed the four nucleotide substitutions [3172 (G ~ T), 3186 (T --* C), 3219 (G--* C) and 3307 (A--*T)] that characterized the predominant B19 type identified in the 1981 outbreak (type IV). With the exception of our isolates from Xi'an, China, all of our other BI9 isolates had nucleotide sequence patterns similar to the 1986-1987 outbreak type (type II). In a recent paper, these authors identified two new B19 strains which they classified as a new genome type, group V (Umene & Nunoue, Despite this high degree of similarity, sufficient nucleotide differences exist to identify B19 genotypes that may have some geographical specificity. B19 isolates from China, and to a lesser extent the UK/Ireland and Korea, appear to form groupings common to these regions. Regional genetic differences among B19 isolates have previously been shown by Kerr eta] . (1995) using a single-stranded conformational polymorphism assay to analyse a limited region of the B19 non-structural protein gone, NS1. Results from our analysis of the Ohio B19 outbreak were of particular interest. These data suggest that although one B19 genotype may predominate in a single community-wide outbreak, multiple B19 lineages can cocirculate. Differences in lineages do not appear to affect clinical outcome, however. Additional isolates need to be examined to clarify community and regional differences among B19 genotypes.
The nucleotide sequence of the VP1 unique region near the VPI/VP2 junction was highly conserved among our isolates. It is possible that the conservation of this region results from the need to maintain signal sequences and/or mRNA conformation required for regulation of mRNA splicing at the VP1/VP2 junction. Of additional interest, most deduced amino acid changes were located in the N-terminal regions of VP1 and VP2 and spread over the C-terminal halves of the structural proteins in a region that, by analogy with the threedimensional structure of canine parvovirus (Tsao et al., 1991) , is bounded by the G and H//-strands (GH loop). Corresponding regions on the structural proteins have been reported to contain important neutralizing epitopes (Yoshimoto etaI., 1991; Sato et aI., 1991; Rosenfeld eta] ., 1992; Saikawa et aI., 1993) . Consequently, amino acid variability in these regions may alter B19 epitopes. No nucleotide changes were identified between positions 3283 and 3715 that conferred amino acid changes in the structural proteins. This region contains several structural elements, including loop 1, s-helix A,//-strands C, D and E of the //-barrel and the five-fold cylindrical structure (Tsao etal., 1991) , and the neutralizing epitope implicated as a binding site for the cellular receptor (Brown etal., 1994) . Conservation of this region may be necessary to maintain the structural and functional integrity of the virus capsid.
In summary, our data suggest that (i) the coding region of the VP1/VP2 structural proteins is relatively conserved among disparate B19 isolates; (ii) genetic changes are unlikely to occur during short-term virus replication in the host and probably do not influence clinical outcome; (iii) a few changes probably occur over the course of a community outbreak and multiple genetic lineages may cocirculate; and (iv) some limited geographical clustering of BI9 genotypes may occur. Our studies also identified both conserved and variable regions in the VP1/VP2 gone and corresponding proteins that may provide a better understanding of the structural and functional properties of B19 and a better guide for future B19 sequencing studies.
